Q9UM73 (ALK_HUMAN) Homo sapiens (Human)
ALK tyrosine kinase receptor UniProtKBInterProSTRINGInteractive Modelling
1620 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
77 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Anaplastic lymphoma kinase (ALK) extracellular fragment of ligand binding region 648-1025 in comple… |
Heteromer Q6UX46; | |||||
| Assess | ||||||
| Crystal structure of ALK in complex with Fab324 |
Heteromer | 4×NAG; | ||||
| Assess | ||||||
| ALK:ALKAL2 complex |
Heteromer Q6UX46; | 2×NAG; | ||||
| Assess | ||||||
| Solution structure of the complex of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) … |
Heteromer O43559; | |||||
| Assess | ||||||
| Solution structure of the complex of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) … |
Heteromer O43559; | |||||
| Assess | ||||||
| Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… |
Heteromer P01889; P61769; | 7×GOL; 5×SO4; | ||||
| Assess | ||||||
| Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… |
Heteromer P04439; P61769; | |||||
| Assess | ||||||
| Structure of the Human ALK GRD bound to AUG | homo-2-mer | 2×CIT; | ||||
| Assess | ||||||
| Anaplastic lymphoma kinase (ALK) extracellular fragment of ligand binding region 673-986 | homo-2-mer | 2×ACT; | ||||
| Assess | ||||||
| Anaplastic lymphoma kinase (ALK) extracellular ligand binding region 673-1025 | monomer | |||||
| Assess | ||||||
| Crystal structure of the TG and EGF-like domains of ALK | monomer | 4×NAG; 1×ZN; 2×NI; | ||||
| Assess | ||||||
| Crystal structure of the apo F1174L anaplastic lymphoma kinase catalytic domain | monomer | 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibi… | monomer | 1×0UV; 1×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802 | monomer | 1×EMH; 4×EDO; | ||||
| Assess | ||||||
| Crystal structure of the apo R1275Q anaplastic lymphoma kinase catalytic domain | monomer | 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of Anaplastic Lyphoma Kinase (ALK) in complex with 4 | monomer | 1×45Q; | ||||
| Assess | ||||||
| Crystal Structure of Anaplastic Lymphoma Kinase (ALK) in complex with 5a | monomer | 1×729; | ||||
| Assess | ||||||
| Crystal Structure of the Anaplastic Lymphoma Kinase (ALK) in complex with 5d | monomer | 1×34Y; | ||||
| Assess | ||||||
| Structure of C1156Y Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-am… | monomer | 1×5P8; | ||||
| Assess | ||||||
| Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibi… | monomer | 1×0UU; | ||||
| Assess | ||||||
| Structure of C1156Y Mutant Human Anaplastic Lymphoma Kinase in Complex with Crizotinib | monomer | 1×VGH; | ||||
| Assess | ||||||
| Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib | monomer | 1×VGH; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor (5R)-8-amino-3-fluo… | monomer | 1×KVC; | ||||
| Assess | ||||||
| Structure of L1196M,G1269A Double Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib | monomer | 1×VGH; | ||||
| Assess | ||||||
| Structure of C1156Y,L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10… | monomer | 1×5P8; | ||||
| Assess | ||||||
| Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibi… | monomer | 1×0US; | ||||
| Assess | ||||||
| Structure of L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-am… | monomer | 1×5P8; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with 2-(5-(6-amino-5-((R)-1-(5-fluoro-… | monomer | 1×AWF; | ||||
| Assess | ||||||
| Crystal structure of human anaplastic lymphoma kinase in complex with a piperidine-carboxamide inhi… | monomer | 1×0JF; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 2-((1R)-1-((3-amino… | monomer | 1×YPW; | ||||
| Assess | ||||||
| Structure of C1156Y,L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with Crizotinib | monomer | 1×VGH; | ||||
| Assess | ||||||
| Crystal structure of human anaplastic lymphoma kinase in complex with piperidine-carboxamide inhibi… | monomer | 1×NZF; | ||||
| Assess | ||||||
| Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-am… | monomer | 1×5P8; | ||||
| Assess | ||||||
| Structure of G1269A Mutant Anaplastic Lymphoma Kinase | monomer | |||||
| Assess | ||||||
| Structure of L1196M Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib | monomer | 1×VGH; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 3-((1R)-1-(5-fluoro… | monomer | 1×GWH; | ||||
| Assess | ||||||
| Structure of L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with Crizotinib | monomer | 1×VGH; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor (10R)-7-amino-12-fl… | monomer | 1×IV7; | ||||
| Assess | ||||||
| A X-ray cocrystal structure of XMU-MP-5 bound to the ALK kinase domain | monomer | 1×F8R; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 3-((1R)-1-(5-fluoro… | monomer | 1×3U9; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with Crizotinib (PF-02341066) | monomer | 1×VGH; | ||||
| Assess | ||||||
| Structure of L1196M Mutant Anaplastic Lymphoma Kinase | monomer | |||||
| Assess | ||||||
| Structure of C1156Y Mutant Anaplastic Lymphoma Kinase | monomer | |||||
| Assess | ||||||
| Structure of Human Anaplastic Lymphoma Kinase Domain in complex with ((2~{R})-2-[5-[6-amino-5-[(1~{… | monomer | 1×AWJ; | ||||
| Assess | ||||||
| Crystal Structure of Anaplastic Lymphoma Kinase Complexed with LDK378 | monomer | 2×GOL; 1×4MK; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 7-amino-3-cycloprop… | monomer | 1×J99; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-fluoro-2-(2H-1,2,3-tr… | monomer | 1×OFG; | ||||
| Assess | ||||||
| Structure of the Human Anaplastic Lymphoma Kinase in Complex with PF- 06463922 ((10R)-7-amino-12-fl… | monomer | 1×5P8; | ||||
| Assess | ||||||
| Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with 2-(5-(6-amino-5-((R)-1-… | monomer | 1×AWJ; | ||||
| Assess | ||||||
| Structure of Human Anaplastic Lymphoma Kinase in Complex With 2-[(1R)-1-{[2-amino-5-(1,3-dimethyl-1… | monomer | 1×6YL; | ||||
| Assess | ||||||
| Crystal structure of the ALK kinase domain in complex with Cmpd 17 | monomer | 1×U4W; 1×GOL; | ||||
| Assess | ||||||
| Structure of Human Anaplastic Lymphoma Kinase Domain | monomer | |||||
| Assess | ||||||
| Crystal Structure of the Anaplastic Lymphoma Kinase Catalytic Domain | monomer | 4×GOL; | ||||
| Assess | ||||||
| Structure of Human Anaplastic Lymphoma Kinase in complex with PHA- E429 | monomer | 1×571; | ||||
| Assess | ||||||
| Crystal Structure of the Anaplastic Lymphoma Kinase Catalytic Domain | monomer | 2×GOL; 1×ADP; | ||||
| Assess | ||||||
| Crystal structure of the ALK kinase domain in complex with Entrectinib | monomer | 1×YMX; | ||||
| Assess | ||||||
| Anaplastic lymphoma kinase catalytic domain complexed with pyrazolopyrimidine derivative of LDK378 | monomer | 2×GOL; 1×4LO; | ||||
| Assess | ||||||
| Structure of Human Anaplastic Lymphoma Kinase Domain in complex with (4-[6-amino-5-[(1~{R})-1-[5-fl… | monomer | 1×25J; | ||||
| Assess | ||||||
| Crystal structure of anaplastic lymphoma kinase (ALK) bound by Brigatinib | monomer | 1×6GY; | ||||
| Assess | ||||||
| Structure of Human Anaplastic Lymphoma Kinase in complex with NVP- TAE684 | monomer | 1×GUI; | ||||
| Assess | ||||||
| hALK in complex with compound 1 (S)-N-(1-(2,4-difluorophenyl)ethyl)-3-(3-methyl-1H-pyrazol-5-yl)imi… | monomer | 1×J4M; | ||||
| Assess | ||||||
| Structure of the Human ALK GRD | monomer | |||||
| Assess | ||||||
| Crystal structure of human ALK with a covalent modification | monomer | 2×COM; 3×EDO; | ||||
| Assess | ||||||
| hALK in complex with 3-(3-methyl-1H-pyrazol-5-yl)pyridine | monomer | 1×GOL; 1×VRM; | ||||
| Assess | ||||||
| hALK in complex with 3-(3-chlorophenyl)-5-methyl-1H-pyrazole | monomer | 1×VTD; 1×EDO; | ||||
| Assess | ||||||
| hALK in complex with 1-[(1R,2R)-1-(2,4-difluorophenyl)-2-[2-(5-methyl-1H-pyrazol-3-yl)-4-(trifluoro… | monomer | 1×VTA; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the Anaplastic Lymphoma Kinase Catalytic Domain | monomer | 1×STU; 2×GOL; | ||||
| Assess | ||||||
| hALK in complex with ((1S,2S)-1-(2,4-difluorophenyl)-2-(2-(3-methyl-1H-pyrazol-5-yl)-4-(trifluorome… | monomer | 2×W47; | ||||
| Assess | ||||||
| hALK in complex with compound 9 (6-(((1S)-1-(5-Fluoropyridin-2-yl)ethyl)amino)-1-(3-methyl-1H-pyraz… | monomer | 1×J3Y; | ||||
| Assess | ||||||
| Structure of F1174L Mutant Anaplastic Lymphoma Kinase | monomer | |||||
| Assess | ||||||
| Crystal structure of the R1275Q anaplastic lymphoma kinase catalytic domain in complex with a benzo… | monomer | 1×I3K; | ||||
| Assess | ||||||
| hALK in complex with compound 7 N-((1S)-1-(5-fluoropyridin-2-yl)ethyl)-1-(5-methyl-1H-pyrazol-3-yl)… | monomer | 1×HKJ; | ||||
| Assess | ||||||
| Anaplastic Lymphoma Kinase with a novel carboline inhibitor | monomer | 1×NRR; | ||||
| Assess | ||||||
| Anaplastic lymphoma kinase (ALK) catalytic domain complexed with novel inhibitor 3-sulfonylpyrazol-… | monomer | 1×CZ4; | ||||
| Assess | ||||||
| Crystal Structure of Human Anaplastic Lymphoma Kinase in complex with 7-azaindole based inhibitor | monomer | 1×3DK; | ||||
| Assess | ||||||
| Solution structure of the chimera of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) … | monomer | |||||
| Assess | ||||||
| Solution structure of the chimera of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) … | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7nx4.1.A | monomer | 0.81 | 1×NI; | 100.00 | ||
| Assess | ||||||
| 3lct.1.A | monomer | 0.78 | 1×ADP; | 99.70 | ||
| Assess | ||||||